Additional studies are needed, however, to further explore the implications of these findings; in particular, to determine the possible mechanisms inducing c-KIT downregulation and to identify other components of the cascade molecular pathway controlled by KIT receptor in order to better understand thyroid cancer development. This evidence concerns the gene KIT and thyroid gland carcinoma.